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Salmonella nomenclature 
in the genomic era: a time 
for change
Marie A. Chattaway1*, Gemma C. Langridge2 & John Wain2,3 
Salmonella enterica nomenclature has evolved over the past one hundred years into a highly 
sophisticated naming convention based on the recognition of antigens by specific antibodies. This 
serotyping scheme has led to the definition of over 2500 serovars which are well understood, have 
standing in nomenclature and, for the majority, biological relevance. Therefore, it is highly desirable 
for any change in naming convention to maintain backwards compatibility with the information 
linked to these serovars. The routine use of whole genome sequencing and the well-established link 
between sequence types and serovars presents an opportunity to update the scheme by incorporating 
the phylogenetically relevant sequence data whilst preserving the best of serotyping nomenclature. 
Advantages include: overcoming the variability in antibody preparations; removing the need to 
use laboratory animals and implementing a truly universal system. However, the issue of trying to 
reproduce the phenotyping gold standard needs to be relaxed if we are to fully embrace the genomic 
era. We have used whole genome sequence data from over 46,000 isolates of Salmonella enterica 
subspecies enterica to define clusters in two stages: Multi Locus Sequence Typing followed by antigen 
prediction. Sequence type—serotype discrepancies were resolved using core SNP clustering to 
determine the phylogenetic groups and this was confirmed by overlaying the antigenic prediction 
onto the core SNP clusters and testing the separation of clusters using cgMLST Hierarchical Clustering. 
This allowed us to define any major antigenic clusters within an ST—here called the MAC type and 
written as ST-serovar. Using this method, 99.96% of Salmonella isolates reported in the UK were 
assigned a MAC type and linked to a serovar name taken from the Kauffmann and White scheme. We 
propose a change for reporting of Salmonella enterica sub-types using the ST followed by serovar.
We identify and name pathogenic organisms because in many cases this informs clinical and public health man-
agement of the diseases they cause. For Salmonella, the second most common cause of bacterial food poisoning, 
specific antibodies are used which recognise cell wall (O) and phase 1 and phase 2 flagella (H) antigens. The 
combination of O:H1:H2 is known as the antigenic formula and each unique combination is given a serovar (or 
serotype) name. Clinically the most critical differentiation for Salmonella is between the enteric fever-causing 
typhoidal serovars and the non-typhoidal (NTS) serovars that most commonly cause gastroenteritis. Enteric 
fever requires antibiotic therapy and if a typhoidal serovar: Salmonella enterica Typhi or Paratyphi, is identified 
then contact tracing is considered. For infection with NTS, specific therapy is not required in the immunocom-
petent host but because of the impact on society, outbreak investigations are often initiated where there is an 
exceedance in the population of a clonal strain. In the UK, if an isolate is identified as Salmonella then under 
the Public Health (Control of Disease) Act 1984 this must, by law, be notified to Public Health England and so 
typing carries both a legal and a public health responsibility. The local Health Protection Team is informed and 
after confirmation and typing from the reference laboratory the case is included in the national databases for 
infection surveillance; outbreak investigations are initiated if appropriate.
Salmonella is currently classified into two species, Salmonella bongori (originally classified as Salmonella 
enterica subspecies V), rarely associated with human infection, and Salmonella enterica. S. enterica is a diverse 
species which infects and colonises many animals including humans. Historically S. enterica classification has 
been based on biochemistry, to define 6 subspecies (I enterica, II salamae, IIIa arizonae, IIIb diarizonae, IV houn-
tenae, VI indica)1. Most human infections involve serovars within subspecies  I2, which are named according to 
the Kauffmann-White  scheme1,3. The first published Kauffmann-White Scheme (1934) described 44  serovars4 and 
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the latest (2007) contains over  25001. The approach can be inconsistent, particularly in cases where sub-typing of 
serovars by the use of biochemical properties is necessary; these are termed biovars (or biotypes). For example, 
isolates with the antigenic formula 4,5,12:b:1,2, are sub-divided by the ability to utilise d-tartrate into S. Paratyphi 
B (d-tartrate − ve) and S. Paratyphi B var Java (d-tartrate + ve). However, the serovar S. Java was withdrawn from 
the Kauffman-White 9th  edition1. Human infection with these biovars results in very different clinical outcomes 
and laboratories in the UK require different containment levels; clear differentiation would therefore be very 
useful. Another example of Salmonella nomenclature issues using the gold standard is Salmonella enterica sub-
species  VII5,6 which has not been formally recognised because biochemical analysis misidentifies  strains1. These 
examples raise the question “should we continue to define Salmonella phenotypically for formal recognition?”.
The introduction of sequence-based methods such as multi-locus sequence typing (MLST) has allowed rea-
nalysis of the S. enterica population structure with phylogenetically relevant methods. Isolates that possess seven 
identical alleles, at the DNA sequence level, of conserved housekeeping genes are assigned to the same sequence 
type (ST). Sequence types cluster into groups of single locus variants where each individual ST shares 6/7 alleles 
with at least one other ST in the group; these clonal  complexes7 are known as eBURST groups (eBGs)8 and relate 
very closely to  serovars9. In 2014, PHE implemented whole genome sequencing (WGS) and validated the naming 
of serovars by referral to  ST10. Another approach is to reproduce the entire Kauffmann-White scheme using the 
genetic sequence of every antigen encoding gene to predict the antigen encoded—genoserotyping. Programmes 
such as  SeqSero11 have been developed with this aim in mind and are very successful; 98% concordance with 
serotyping reported from routine use on 520 isolates (20 serotypes)12 but the genetic basis for some antigens, 
particularly the cell wall (O) antigens remains elusive. The combination of the two sequence based approaches, 
phylogenetic methods with genoserotyping, for example the Salmonella in Silico Typing Resource (SISTR)13, 
reports 94.6% concordance on a dataset comprised of 4188 Salmonella genomes. However, comparison with the 
gold standard of the Kauffmann-White scheme is not perfect and remains a controversial  topic14. Where WGS 
had been  implemented10 the use of genoserotyping has shown 89% concordance with the gold standard: of 17,899 
confirmed Salmonella laboratory results reported between April 2016 and March 2018, the serovar of 15,945 
(89.1%) Salmonella were reported by using sequence type (ST) combined with SeqSero. However, for complete 
resolution 3,678 (20.6%) isolates required antibody-based serotyping using antibodies raised in rabbits. The 
main reason for antibody-based serotyping was discrepancy between the sequence predicted serovar and that 
reported by the sending laboratory with a smaller proportion attributed to novel Salmonella and differentiation 
of complex Salmonella  groups14.
Salmonella typing is in transition, the Kauffmann-White Scheme has not been updated since 2007, and there 
is not yet agreement on what should replace it—genomic approaches are generally considered to be the most 
promising but consensus is needed to ensure a standardisation of approach. One of the main issues is with iso-
lates for which the link between serovar and DNA sequence data is not clear. These problematic isolates fall into 
three groups: (1) unknown genetics of antigen production—genoserotyping has not been defined; (2) lack of 
concordance with gold standard—commonly serotyping differentiates two isolates which have the same ST; and 
(3) novel STs—new STs which have not been formally approved. If we continue to follow the formally recognised 
gold standard then serotyping with antibodies raised in rabbits will remain necessary for the foreseeable  future14. 
The solution may be with international groups such as PulseNet International, a global network dedicated to 
laboratory-based surveillance for food-borne diseases which is the most widely accepted process for reviewing 
Salmonella typing. Their vision is the implementation of WGS  surveillance15 however, as the focus of PulseNet 
is to reach a consensus for the definition of strains at the SNP and allele level for outbreak detection, the naming 
of Salmonella isolates at the serovar level remains in flux.
In this publication we look at the practical issue of naming Salmonella at the serovar level. We present 
analysis of the sequence data generated at Public Health England from all Salmonella enterica isolates referred 
from England and Wales to the Salmonella Reference Unit over 5 years; we focus on the problematic isolates 
and propose a method for naming all Salmonella isolates using WGS data—our aim is to remove the need for 
antibody based serotyping.
Methods
Salmonella enterica subspecies enterica sequenced  isolates14 reported between January 2014 and 21st June 2019 
selected for this study included 46,268 strains. Data was analysed as follows:
Serovar inference using MLST. Analysis was undertaken on the 46,268 strains to understand the number 
of isolates in which ST alone could be used for identification without the need for any further testing.
Assigning isolates to novel STs. Since routine implementation in 2015, sequences that did not map to 
any known sequence type (i.e. novel ST) were assigned a new sequence type via PubMLST (https:// pubml st. org/ 
Salmo nella/) and validated by antibody-based testing. In brief, antibody-based testing was undertaken using 
in house sera antibodies against the isolate antigen using slide agglutination, microtitre dilution and Craigie 
motility agar methods according to the Kauffmann-White  scheme1,3. At the time of this study, antibody-based 
serotyping was performed on three independent isolates before an ST was validated and then used to define a 
 serovar14. Novel STs were also compared against  SeqSero11 for identification and unresolved serovars were then 
assessed using predicted ST serovars in Enterobase as previously  described16.
Defining major antigen clusters (MACs) within problematic groups. The groups that could not 
be designated a serovar based on ST and analysis of antigen encoding genes were defined as being problematic. 
Usually this was because one ST contained more than one serovar, or the serovar prediction programmes were 
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not able to assign a serovar. A random subset of strains from each group also had antibody-based testing as 
described  above1,3. Problematic groups were analysed further to determine if the different serovars with the same 
ST came from distinct phylogenetic groups or were in fact from a single population—we term this the MAC type 
which was achieved as follows.
Somatic antigen clusters. At the time of writing, the available serovar prediction programmes were not able to 
resolve all O antigens from the genome sequence. Isolates from STs containing multiple serovars (defined by 
serological based typing of O antigens) were tested for phylogenetic separation using core genome SNP cluster-
ing.
Flagella clusters. We defined H antigens using serovar prediction programmes and reproduced the names in 
the Kauffman-White scheme for most of the problematic STs using SeqSero—we checked three for concordance 
with antibody-based serotyping. The necessity of using fliC sequences as a differentiating factor within a ST has 
been  questioned9, therefore variation at the genomic level for serovars within a single ST that differed only by an 
H antigen was investigated using core genome SNP clustering.
Core genome SNP clustering. All data were analysed in  Galaxy17. Raw Illumina sequence data (previously gen-
erated by PHE) was downloaded from the NBCI sequence read archive (SRA, https:// www. ncbi. nlm. nih. gov/ 
sra). Strains with associated laboratory serovar identifications were assembled using  SPAdes18 (v3.12.0 + galaxy1) 
with default parameters and assessed with  QUAST19 (v5.0.2). Per group, a high quality reference was selected 
that had the fewest contigs > 1000 bp and had the largest single contig. Reference assemblies were reduced to 
contigs > 1000 bp using  seqtk_seq20 (v1.3.3) with the -L 1000 flag. All sequenced isolates per group were com-
pared to the reference using  snippy21 (v3.2) and snippy-core was used to generate a core SNP alignment. Maxi-
mum likelihood phylogenetic trees were generated using IQ-TREE22 (Galaxy version 1.6.12) and visualised with 
associated metadata in  iTOL23. Differences in fliC and fljB nucleotide sequences were assessed by sequence 
comparison in  Seaview24 (v4.7) after annotation of the reference sequence using  prokka25 (Galaxy version 1.13). 
As ST226 (Carrau/Gatow) only comprised 9 isolates in the PHE sequences, this group was supplemented with 
129 isolates obtained from Enterobase with the same ST and whole genome sequence available for download. 
Isolates assigned serovar Bredeney came from either ST241 or ST897. To assess whether these truly represented 
different phylogenetic groups, a maximum likelihood tree containing all isolates from ST241 and ST897 was 
generated and visualised as before.
Hierarchical clustering. Hierarchical Clustering of the groups was assessed using tools in Enterobase, an open 
access public database, as previously  described26 to define the number of alleles (3002 cgMLST genes) at which 
the MAC types differentiate. This enables readers to differentiate the MAC types who may not have access to 
bespoke phylogenetic methods.
Major Antigenic Cluster (MAC) types were designated to both serovars if serovars were genetically distinct 
and differed by a minimum 100 alleles using cgMLST Hierarchical Clustering, otherwise the most common 
serovar was assigned as the MAC  type16,26.
Results
DNA sequence data was available from 46,268 subspecies I Salmonella isolates sequenced at PHE over the period 
January 2014 to June 2019 comprising 550 named serovars and 1704 STs. In this study, a total of 11,605/46,268 
(25%) isolates had antibody-based testing undertaken. Using traditional serological techniques during this time 
period, there were 970 (2.1%) isolates reported as unnamed serovars. Using a genomic approach and utilising the 
ST to associate sequence to serovar, the naming of 43,657 (94.37%) isolates was possible, leaving 2601 (5.63%) 
requiring further analysis. These isolates fell into two main categories, 1774 (3.85%) isolates were associated with 
‘problematic groups’ and 827 (1.78%) isolates were novel STs. SeqSero could differentiate 1,607 isolates from 
problematic groups in accordance with MAC typing and 806 isolates with novel STs. This left a total of just 172 
isolates (0.37%) from problematic groups that couldn’t be fully resolved using ST and SeqSero according to the 
Kaufmann and White Scheme (see Supplementary. Fig S1), further details described in below.
Problematic groups (1774 isolates). Each problematic group was investigated (Table 1) and the dif-
ferences in the somatic (O) antigen or flagella (H) antigen were recorded. Clustering on core SNP similarity 
was performed and the serovar name was overlaid to visualise the distribution of serovars on the SNP tree—
where the serovars clustered independently, a major antigen cluster or MAC type was defined within the ST. See 
Fig. 1A,B for examples and Supplementary Figs. S2–S14 for details.
Somatic clusters. There were three STs containing multiple serovars differentiated by O antigens. Compari-
son between antibody-based serotyping and the SeqSero predictor programmes showed that SeqSero could not 
predict all antigenic expressions for the somatic antigen. The common antigens involved in the sequence-based 
naming issues were O22 and O23 (ST1985, Fig. 1B), O6,7 and O6,14 (ST226, see Supplementary Fig. S9) and 
O6,8 and O8,20 (ST2256, see Supplementary Fig. S1). Phylogenetic clustering showed that within a single ST, 
two serovars, if differentiated only by O antigen, did not separate into distinct clusters (Table 1). The exception 
to this was the serovar Carrau or Gatow (ST226, See supplementary Fig. S9).
4
Vol:.(1234567890)
Scientific Reports |         (2021) 11:7494  | https://doi.org/10.1038/s41598-021-86243-w
www.nature.com/scientificreports/
Flagella clusters. There were fourteen STs containing multiple serovars with an H antigen difference (Table 1). Com-
parison between antibody-based serotyping and the SeqSero predictor programmes showed that SeqSero could pre-
dict all antigens from the fliC and fljB gene sequences. The most common antigens involved in the sequence-based 
naming issues were the H antigens: fliC,: l,v; e,h; z10; z23; z13; a; b; d; r and fljB: 1,2; ; 1,5 1,7; z-15; e,n,x. Phylogenetic 
clustering showed that the majority of serovars found in the same ST, which differed by H antigen, formed distinct 
clades (ST20-Fig. 1A, ST49-Fig. S2, ST582-Fig. S3, ST22-Fig. S4, ST241-Fig. S5, ST897-Fig. S6, ST48-Fig. S7, ST909-
Fig. S11 and ST101-Fig. S13) and so were considered as separate entities (Table 1). There was also an example of a 
polyphyletic serovar found in two problematic groups defined as MAC type ST241-Bredeney and ST897-Bredeney 
but still genetically distinct (Table 1, Fig. S14). The exceptions were two groups that contained mixed clades (Table 1, 
ST2019-Fig. S8 and ST684-Fig. S10) which were differed by the l,v and l,v,z13 antigen (Table 1).
Major antigenic cluster (MAC) typing. We then used core SNP clustering to test if the different serovars, defined 
by traditional serotyping, separated into distinct phylogenetic clusters or were distributed together as a mixed 
cluster; this we named MAC typing and the groupings were confirmed by cgMLST Hierarchal Clustering. Where 
the phylogenetic clusters contained mixed antigenic types the most common serovar seen by the laboratory was 
used to name all isolates in that cluster. Phylogenetic analysis and cgMLST Hierarchal Clustering showed that 
distinct MAC types varied in their genetic relatedness and split from a range of 100 alleles level (ST22, see Sup-
plementary Fig. S4) to 900 alleles level (ST582, see Supplementary Fig. S3) (Table 1).
Novel STs. Analysis in this study showed that novel STs (n = 827) make up a small percentage of Salmonella 
enterica subspecies enterica but the number of new STs arising continues to be stable accounting for 1.8–2.4% of 
Salmonella enterica subspecies enterica reported each year (Table 2). The novel bioinformatic pipeline was not 
fully implemented in 2014 and novel STs were unrepresented in that year.
In summary, of the 46,268 Salmonella analysed, using genomic testing and a polyphasic approach of ST, 
SeqSero and MAC typing enabled 99.96% of isolates to be reported as a named serovar. For 21 (0.04%) novel ST 
isolates, only a partial antigenic profile, according to the Kauffman-White Scheme could be characterised (see 
Supplementary Fig. S1).
Table 1.  Proposed reporting guidelines for Salmonella using genome sequence data to define the major 
antigenic clusters (MACs). a Not used in MAC typing but presented for comparison and explanation. b Any 
serotype prediction programme can be used though some antigens cannot be distinguished. c Figure shows core 
SNP cluster for each antigenic type. d Hierarchical Clustering Level at which the serovars can be differentiated 
genetically.  No. = number of MAC type, % of the 46,268 Salmonella reported.




clustering level to 
differentiate Figure
20 Brandenburg H: l,v Distinct 24 0.05 ST20-Brandenburg HC400_11346 Figure 1A
20 Sandiego H1: e,h Distinct 26 0.06 ST20-Sandiego HC400_2255 Figure 1A
1985 Bahati or Durham O:22 or O:23 Mixed 66 0.14 ST1985-Durham N/A—interspersed Figure 1B
49 Saintpaul H: e,h Distinct 75 0.16 ST49-Saintpaul HC200_8 Figure S2
49 Haifa H: z10 Distinct 130 0.28 ST49-Haifa HC200_1433 Figure S2
582 Kottbus H: e,h Distinct 42 0.09 ST582-Kottbus HC900_7054 Figure S3
582 Chailey H: z23 Distinct 6 0.01 ST582-Chailey HC900_17 Figure S3
22 Braenderup H2: e,n, z15 Distinct 607 1.31 ST22-Braenderup HC100_185 Figure S4
22 Larochelle H2: 1,2 Distinct 19 0.04 ST22-Larochelle HC100_1136, 25669, 2664, 28707 Figure S4
241 Bredeney H: l,v Distinct 45 0.10 ST241-Bredeney HC200_2494, HC200_1335 Figure S5, S14
241 Schwarzengrund H: d Distinct 12 0.03 ST241-Schwarzengrund HC200_17392 Figure S5
897 Bredeney H2: 1,7 Distinct 8 0.02 ST897-Bredeney HC400_31544 Figures S6, S14
897 Kimuenza H2: e,n,x Distinct 9 0.02 ST897-Kimuenza HC400_24937 Figure S6
48 Panama H: l,v Distinct 197 0.43 ST48-Panama HC400_369 Figure S7
48 Miami H: a Distinct 4 0.01 ST48-Miami HC400_2307, HC400_67476 Figure S7
2019 Napoli or Zaiman H:z13 or H:v Mixed 21 0.05 ST2019-Napoli N/A—interspersed Figure S8
226 Carrau O:6,14 Distinct 4 0.01 ST226-Carrau HC400_363 Figure S9
226 Gatow O:6,7 Distinct 3 0.01 ST226-Gatow HC400_59526 Figure S9
684 Uganda or Sinstorf H:l,v,or H: l,z13 Mixed 75 0.16 ST684-Uganda N/A—interspersed Figure S10
909 Bareilly H: 1,5 Distinct 299 0.65 ST909-Bareilly HC200_899 Figure S11
909 Richmond H: 1,2 Distinct 86 0.19 ST909-Richmond HC200_101 Figure S11
2256 Brunei or tananarive O: 8, 20 or O: 6, 8 Mixed 7 0.02 ST2256-Brunei N/A—interspersed Figure S12
101 Bochum H: r Distinct 4 0.01 ST101-Bochum HC900_491 Figure S13
101 Wien H: b Distinct 5 0.01 ST101-Wien HC900_95 Figure S13
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Discussion
Based on the analysis reported here, we have shown that MLST and SeqSero can differentiate the majority of 
Salmonella previously defined isolates into major antigenic clusters—MAC types, which map to serovars in the 
Kauffmann-White scheme. The assignment of a MAC type to the 0.37% of problematic and novel isolates resulted 
in the total genomic identification of 99.96% of isolates (see Supplementary Fig. S1). The 0.04% of isolates which 
could not be fully resolved in terms of the full antigen prediction was still an improvement to 2.1% of isolates that 
could not be resolved via antibody-based testing which were reported as ‘unnamed Salmonella’. Although MAC 
typing of problematic groups depended initially upon core genome SNP typing, this will not need to be repeated 
for the STs described here. Assignment of a serovar name to an isolate with a sequence type can be achieved 
through many programmes freely available  online11,13,26. Laboratories using WGS can use this publication to 
ascribe serovar names to the 14 problematic STs described here. This publication also provides a road map for 
assigning serovar names to any new problematic STs seen in other regions of the world.
There were fourteen polyserovar groups addressed in this paper which contains a comprehensive dataset of 
Salmonella reported in England and Wales, it is likely that there will be more groups in the future and in different 
regions of the world. Analysis of the groups showed that genoserotyping programmes can usually differentiate 
polyserovars that differ by the flagella antigen using current software programmes such as  SeqSero11 and that 
these polyserovars, were genetically different. Therefore, those serovars which form distinct clades, should con-
tinue to be differentiated even though they are in the same ST. There are exceptions to this rule including those 
differentiated by the lv,lz13 antigen (Serovar Uganda or Sinstorf) or the H:z13 or H:v antigen (Serovar Napoli 
or Zaiman) which formed mixed clades. This is likely due to the quality or specific binding properties of the 
antibodies. Interpretation of results may also be a factor as shown by MAC types ST22-Braenderup (H:e,n,z15) 
Figure 1.  (A) Phylogenetic analysis of MAC types Brandenburg and Sandiego (ST20). Representative strains 
were serotyped and serotype result is highlighted in blue (Sandiego) or red (Brandenburg). (B) Phylogenetic 
analysis of MAC types Bahati and Durham (ST1985). Representative strains were serotyped and serotype result 
is highlighted in blue (Bahati) or red (Durham).
Table 2.  Number of Novel STs identified each year at PHE. *Automated Novel ST pipeline implemented in 
2015 so Novel STs underrepresented in 2014 in this analysis.
Year No. novel ST Total Salmonella reported % of novel ST to Salmonella reported
2014* 18 6406 0.3*
2015 165 8374 2.0
2016 217 8930 2.4
2017 180 9381 1.9
2018 180 10,143 1.8
2019 (Jan–June) 67 3034 2.2
Total 827 46,268 1.8
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and ST22-Larochelle (H:1,2), a clearly distinct group, in which antibody-based results incorrectly identified some 
of the strains (see Supplementary Fig. S8), (Table 1, Figs. 1A, see Supplementary Figs. S2–S7, S10, S11, S13).
Polyserovars that differed by the somatic antigen could not be differentiated by WGS genoserotyping software 
programmes and the majority were not genetically different (Table 1, Fig. 1B, see Supplementary Fig. S12). With 
the exception of the distinct MAC Types such as ST226-Gatow and ST226-Carrau (see Supplementary Fig. S9). 
Even though genoserotyping cannot differentiate these groups, Hierarchical Clustering can be used, in this case 
at the 400-allele level (Table 1). The exceptions from the majority of strains where differing flagella antigens 
are genetically distinct and differing somatic antigens are mixed clades is the reason why assessment of each 
problematic group for MAC typing is initially required. There does not appear to be any biological relevance 
to differentiating groups with mixed clades and we recommend that the most common name is used for mixed 
clade groups while we wait for international consensus. Using the most common MAC type will not be consistent 
across all countries but the use of public databases, such as Enterobase, may assist in deciding the most com-
mon international name. Ultimately, it is important for the classification scheme to be updated to ensure global 
consistency of nomenclature. Our recommendation is to withdraw (such as S. Bahati) or reinstate historical 
serovar names (such as S. Java) as defined by the Kauffmann-White scheme based on an ST-serovar convention.
If we are to replace serology with sequencing entirely then the current approach of validating novel STs via 
serotyping needs to change. The analysis in this study showed that novel STs (n = 827) made up 1.78% of Salmo-
nella referred (see Supplementary Fig. S1) and that this percentage was stable over 4 years (Table 2). Our data 
suggests the possibility of an open population with a fairly consistent number of novel STs emerging each year 
(Table 2) or a massive population size of Salmonella world-wide. Either way, we have not reached a plateau for the 
discovery of new STs and so we need a way to name them. Currently PHE validate all novel STs phenotypically 
when only 0.04% can’t be genotypically predicted due to issues with antigen prediction software. Salmonella has 
a complex system for expression of antigens and the current publicly available prediction software,  SISTR13 and 
 SeqSero11 are not able to predict all somatic antigens due to the way somatic antigens are encoded and expressed. 
There are also issues where predictions will not always relate to phenotypic  expression12,27. This may be due to 
mutations in the gene or non-specificity of the antigens as rearrangements and mutations cannot be easily pre-
dicted by gene detection in software programmes and discrepancy between genotype and phenotype may occur. 
Historical methods for naming new serotypes will also play a role, if the antigen had historically reacted with 
a known antibody, even if non-specific, it was recorded as being the same. We see evidence of this when look-
ing at sequences of the flagella from 6,7:c:1,5 strains (S. Decatur and the S. Choleraesuis/S. Paratyphi C group, 
originally differentiated by biotyping) in which antibody-based testing is not efficient as distinguishing distinct 
sequences of fljB genes which has resulted in serological conflation of these genetically unrelated  serovars9. We 
see the same issue where genoserotyping can’t differentiate historical biotyped groups with S. Paratyphi B and 
S. Paratyphi B var Java, which can’t be differentiated serologically. They are genetically distinct with the former 
causing invasive  disease28 and fall into distinct ST  groups9 and therefore should be clearly differentiated in name. 
The use of MAC typing could also resolve these groups without the need for biochemical testing to differentiate 
biotypes. Essentially, SISTR and SeqSero databases are based on the K&W scheme which depends upon the 
excellent but slightly flawed serotyping.
Currently for novel Salmonella, antibody-based serology is still undertaken to comply with the Kauffmann-
White scheme which does not take the genotype into account. The impact of continuing to use antibody based 
serological methods includes: the continued use of animal model products; increase in turnaround times by 
3–14 days; additional staff resources and expertise; and additional quality testing systems and cost. Serology still 
holds value in microbiology, retaining the skills in specific institutes (as with viral culture) will be important for 
the future. It is also useful for frontline laboratories where presumptive identification is required and in low to 
middle income countries who don’t have access to molecular techniques. At the very least however, the concept 
of using ST, genotypic expression and MAC typing for defining Salmonella where genomic methods are available 
should be adopted. Particularly in reference laboratories and accepting that 0.04% may not predict all phenotypic 
expressions but that there is a very low impact in clinical or public health management. It is unlikely that a full 
reform of the Kauffmann and White naming scheme based on genetic differences will occur, to differentiate 
polyphyletic or polyserovar groups but the use of MAC types will resolve Salmonella nomenclature issues.
This study/opinion piece supports the continued use of historical names, they are valuable in terms of inter-
national communication and the understanding of biological, clinical, transmission and outbreak association of 
groups. It is recommended that Salmonella are named genetically as the gold standard where these practices are 
available. To define new MAC types, either SNP or cgMLST hierarchical clustering approaches, with a minimum 
of three of each serovar, could be used as this study shows. Although these methods can be performed via bespoke 
bioinformatic platforms, both methodologies are also available on Enterobase and don’t require extensive bioin-
formatic skills. Having a strict cut off to define MAC types is not possible because the genetic variability within 
different groups of Salmonella varied between HC100-HC900 for defining MAC types (Table 1). Therefore, these 
distinctions would be required on a group by group basis.
Definition of Salmonella in the genomic era. The MAC type can be inferred by validated genomic 
approaches with validated databases, for example by  ST9,10, prediction software  programmes11,13,27 and MAC 
typing (this study). It should be recognised that for novel STs, not all somatic antigens will be predicted and 
so an agreed approach to naming is required. It is therefore recommended that Salmonella strains are named 
first by Salmonella species and subspecies and then the MAC type (ST or provisional ST plus historical serovar 
name or Serogene). Examples of MAC types: (a) S. enterica ST34—S. Typhimurium-monophasic variant (b) S. 
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Conclusion
A previous report from PHE, using the same dataset, stated that almost half of sequenced Salmonella isolates 
that were checked phenotypically were due to discrepancies with the findings from the serology of sending 
 laboratory14. We show here that this is not necessary as the serovar designation from genome sequence data alone 
can be trusted and used for reporting. Using WGS, 99.96% of Salmonella isolates reported in the UK can currently 
be assigned a MAC type name taken from the  MLST9,16 and genetic antigenic profile in line with the Kauffman 
and White Scheme 1,3. We recommend a change to using sequence data for the routine naming of all Salmonella.
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